Protein Modeling
Protein modeling notes cover folding, structure prediction, protein representation learning, and links to downstream structure-based tasks.
A broad protein modeling view is:
where is a protein sequence, is optional observed or predicted structure, is optional context, and the output can be a representation , coordinates , or a task label .
Route Map
| Question | Start |
|---|---|
| What object is being modeled? | Protein, Sequence, Structure |
| How is the protein represented? | Protein representation, Protein language model, Sequence, 3D structure |
| Does the method use evolutionary context? | Multiple sequence alignment, Protein domain |
| Does the method predict coordinates or contacts? | Protein structure prediction, Contact map, Coordinate prediction |
| Is residue numbering or chain mapping important? | Residue indexing, Sequence-structure alignment |
| Is this linked to binding or docking? | Structure-based modeling, Protein-ligand complex, Protein-ligand interaction |
| What split tests transfer? | Protein family split, OOD generalization |
Representation Levels
| Level | Unit | Common Representation | Common Claim |
|---|---|---|---|
| token | amino acid residue | token embedding, logits | masked residue prediction, residue annotation |
| segment | motif, domain, region | pooled embedding, local features | function, site, domain classification |
| chain | full protein sequence or structure | sequence embedding, structure embedding | family, function, stability, localization |
| binding site residues and coordinates | pocket graph, grid, local frame | ligand binding, docking context | |
| complex | protein plus partner | interaction graph, pair representation | binding, pose, interface, affinity |
The same architecture can mean different things at different levels. A Transformer over residues is not the same claim as a graph model over a protein-ligand complex.
Modeling Modes
| Mode | Typical Input | Typical Output | Evaluation Risk |
|---|---|---|---|
| sequence representation | sequence, MSA, domain annotation | embedding, residue features | homolog leakage, family imbalance |
| structure prediction | sequence, template, MSA | coordinates, distances, contacts | template leakage, atom/residue mapping |
| functional prediction | sequence or structure | class, site, activity, property | label semantics, assay/source leakage |
| interaction modeling | protein plus ligand, peptide, protein, or nucleic acid | binding score, pose, contact, interface | split must control both interaction sides |
| generative design | sequence, backbone, pocket, constraints | sequence, structure, complex, design candidates | validity, novelty, diversity, downstream assay gap |
Sequence, Structure, and Context
Protein papers often mix three different information sources:
Keep these separate when reading a method:
| Source | What It Provides | Risk |
|---|---|---|
| sequence | residue order and identity | homolog leakage and duplicate sequences |
| MSA | evolutionary co-variation | train/test family overlap and database time leakage |
| template | structural prior | template leakage into structure benchmarks |
| predicted structure | coordinates with model bias | circular evidence if used as ground truth-like input |
| pocket or ligand context | local interaction condition | ligand-defined pocket leakage |
| assay or function label | measured endpoint | source, organism, construct, and label ambiguity |
Common Objectives
| Objective | Sketch | What It Trains |
|---|---|---|
| masked residue prediction | sequence representation | |
| autoregressive protein modeling | sequence distribution and generation | |
| contrastive protein learning | representation invariance | |
| distance/contact prediction | or BCE over contacts | pair geometry |
| coordinate prediction | after an alignment policy | structure geometry |
| functional prediction | downstream task behavior |
The objective should be linked to the evidence. A good language-modeling loss does not automatically prove structure, binding, or functional transfer.
For sequence-only models, the distinction is:
Function, binding, stability, and design claims need downstream labels, structural evidence, or experimental validation.
Evidence Fields
| Field | Why It Matters |
|---|---|
| sequence source | duplicate proteins and homologs define leakage risk |
| structure source | experimental, predicted, template-derived, and relaxed structures support different claims |
| representation unit | token, residue, domain, chain, complex, pocket, or full structure changes the task |
| split unit | row split, protein family split, fold split, target split, and complex split test different generalization claims |
| metric | sequence, coordinate, ranking, binding, and generation metrics are not interchangeable |
| uncertainty | replicate noise, structural ambiguity, seed variance, and family imbalance affect interpretation |
Paper Note Checklist
| Check | Question |
|---|---|
| object | Is the unit residue, chain, pocket, complex, family, or assay row? |
| representation | Is the model using sequence, MSA, predicted structure, experimental structure, or ligand context? |
| split | Does the split remove homologs, related structures, and shared interaction partners? |
| template policy | Are templates, predicted structures, and database dates controlled? |
| metric | Does the metric match the claimed output: sequence, contact, coordinate, binding, or function? |
| downstream gap | Does the benchmark actually test the biological or chemical use case? |